/ Glenmark Pharmaceuticals Receives Tentative ANDA Approval ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Friday, 31 March 2017

Glenmark Pharmaceuticals Inc., USA (Glenmark), has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for Milnacipran Hydrochloride Tablets, 12.5 mg, 25 mg, 50 mg and 100 mg, the generic version of Savella Tablets, 12.5 mg, 25 mg, 50 mg and 100 mg of Allergan Sales, LLC.

Glenmark Pharma's stock is trading higher by 0.4% on BSE at Rs 867.4 per share in Friday’s morning trade. The BSE Healthcare index is also trading in positive territory, higher by 0.3% at 15333 levels.

Pharma major, Sun Pharma is the biggest contributor to the index gains in the morning trade. Torrent Pharma's stock is the top gainer in the index, trading higher by 3.13% at Rs 1535 per share.

Though the major indices in the market are showing weakness in the morning hours of Friday’s trade, the pharma stocks are trading firmly, outperforming the major indices.
For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 
Give a Missed Call for Free Trial - 09699997717